Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of pain and fever
3.2.1.2 Growing number of surgical procedures
3.2.1.3 Advantages of intravenous administration
3.2.1.4 Growing adoption in critical care settings
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost compared to oral alternatives
3.2.2.2 Side effects and health risks
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Surgical
5.3 Non-surgical
Chapter 6 Market Estimates and Forecast, By Indication, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Pain management
6.3 Pyrexia
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals and clinics
7.3 Ambulatory surgical centers (ASCs)
7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 AdvaCare Pharma
9.2 Altan Pharma
9.3 B. Braun SE
9.4 Cipla Inc.
9.5 Criticine Care
9.6 Fresenius Kabi
9.7 GNova Biotech
9.8 Lupin
9.9 Mallinckrodt Pharmaceuticals
9.10 Pfizer
9.11 Solitaire Pharmacia
9.12 Unital Pharmaceuticals
